Power Law company profile

Reata Pharmaceuticals

Biotech & Life Sciences · Plano, United States · Founded 2002 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.40B

Market cap · 2026

Revenue

$2.2M

Latest reported FY

Investors

6 investors on Reata Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Startech Early Ventures

Series B+ 5 investors entered at this stage

Novo Holdings

Cardinal Investment Co.

CPMG

Novo Seeds

The University of Texas System

Patent intelligence

$354M patent portfolio · 76 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$354M

5.5% of market cap · comparable to top peer Actelion Pharmaceuticals ($361M)

76 active patent families

Where Reata Pharmaceuticals innovates Medicinal chemistryPharmaceutical SubstancesPharmaceutical drugPerylene derivativesPharmacology

Above peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

Reata Pharmaceuticals on the five Patsnap quality dimensions

Reata Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Reata Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Reata Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Reata Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo